Revenue for AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's current revenue (TTM) is $58.74B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
AZN
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$58.74B
YoY change
+8.6%
5Y CAGR
+17.2%
Peak year (2025)
$58.74B
Cumulative revenue
$854.04B
Revenue history chart for AstraZeneca (AZN) from 1990 to 2025
Revenue history table for AstraZeneca (AZN) from 1990 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $58.74B | +8.6% | ||
| 2024 | $54.07B | +18.0% | ||
| 2023 | $45.81B | +3.3% | ||
| 2022 | $44.35B | +18.5% | ||
| 2021 | $37.42B | +40.6% | ||
| 2020 | $26.62B | +9.2% | ||
| 2019 | $24.38B | +10.4% | ||
| 2018 | $22.09B | -1.7% | ||
| 2017 | $22.46B | -2.3% | ||
| 2016 | $23.00B | -6.9% | ||
| 2015 | $24.71B | -6.9% | ||
| 2014 | $26.55B | +2.9% | ||
| 2013 | $25.81B | -7.7% | ||
| 2012 | $27.97B | -16.7% | ||
| 2011 | $33.59B | +1.0% | ||
| 2010 | $33.27B | +1.4% | ||
| 2009 | $32.80B | +3.8% | ||
| 2008 | $31.60B | +6.9% | ||
| 2007 | $29.56B | +11.6% | ||
| 2006 | $26.48B | +10.5% | ||
| 2005 | $23.95B | +11.8% | ||
| 2004 | $21.43B | +13.7% | ||
| 2003 | $18.85B | +5.6% | ||
| 2002 | $17.84B | +8.3% | ||
| 2001 | $16.48B | -9.0% | ||
| 2000 | $18.12B | +19.7% | ||
| 1999 | $15.13B | +33.7% | ||
| 1998 | $11.32B | +31.8% | ||
| 1997 | $8.59B | -6.5% | ||
| 1996 | $9.18B | +21.3% | ||
| 1995 | $7.57B | +8.1% | ||
| 1994 | $7.00B | +6.6% | ||
| 1993 | $6.57B | +8.8% | ||
| 1992 | $6.03B | -17.9% | ||
| 1991 | $7.35B | +0.0% | ||
| 1990 | $7.35B | — |
Revenue values are taken from AstraZeneca's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, AstraZeneca (AZN) reported revenue of $58.74B – grew 8.6% year-over-year.
Across 2020–2025 (5 years), AstraZeneca revenue produced a CAGR of +17.2% – sustaining 7 straight years of year-over-year growth.
2025 marks the peak revenue at $58.74B, with the historical low of $6.03B recorded in 1992.
Within Healthcare, AstraZeneca (AZN) ranks 7th among 8 peers we track. The peer median for revenue is $65.09B.
AstraZeneca Revenue by Year
AstraZeneca Revenue 2025: $58.74B
AstraZeneca revenue in 2025 was $58.74B, grew 8.6% from 2024. This figure represents the highest annual value in the available history.
AstraZeneca Revenue 2024: $54.07B
AstraZeneca revenue in 2024 was $54.07B, grew 18.0% from 2023.
AstraZeneca Revenue 2023: $45.81B
AstraZeneca revenue in 2023 was $45.81B, edged up 3.3% from 2022.
AstraZeneca Revenue 2022: $44.35B
AstraZeneca revenue in 2022 was $44.35B, grew 18.5% from 2021.
AstraZeneca Revenue 2021: $37.42B
AstraZeneca revenue in 2021 was $37.42B.
See more financial history for AstraZeneca (AZN).
Sector peers — Revenue
Companies in the same sector as AstraZeneca, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $44.56B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is AstraZeneca's revenue?
- Latest reported revenue for AstraZeneca (AZN) is $58.74B (period ending December 31, 2025).
How has AstraZeneca revenue changed year-over-year?
- AstraZeneca (AZN) revenue changed +8.6% year-over-year on the latest annual filing.
What is the long-term growth rate of AstraZeneca revenue?
- AstraZeneca (AZN) revenue compound annual growth rate is +17.2% over the most recent 5 years available.
When did AstraZeneca revenue hit its highest annual value?
- AstraZeneca revenue reached its highest annual value of $58.74B in 2025.
What was AstraZeneca revenue in 2024?
- AstraZeneca (AZN) revenue in 2024 was $54.07B.
What was AstraZeneca revenue in 2025?
- AstraZeneca (AZN) revenue in 2025 was $58.74B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
AZN Overview
Company profile, financial tools, and key metrics
AZN Revenue Counter
Earns $1,863 every second. See per minute, hour, and day.
AZN Earnings Counter
Earns $324.23 per second net profit. See per minute, hour, and day.
AZN Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
AZN What If Invested
What if you had invested $1,000? See historical returns from any date.
AZN How It Makes Money
Discover visual breakdown of $58.74B in revenue — where it comes from and where it goes.
AZN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AZN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AZN Daily Price Character
Steady · 49.4% historical win rate (green days). Streaks & record days.
AZN Buybacks
0.16% TTM buyback yield. Shareholder yield & SBC comparison.
AZN Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
AZN Dividend Profile
Yield: 1.73%. Safety: 6/8. See full history.
AZN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AZN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.